OmniAb Inc. Cash Flow Conversion Efficiency
OmniAb Inc. cash flow conversion efficiency. Based on the latest financial reports, OmniAb Inc. (OABI) has a cash flow conversion efficiency ratio of 0.010x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.68 Million) by net assets ($260.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of OmniAb Inc. (2019–2025)
Cash flow conversion efficiency of OmniAb Inc. from 2019 to 2025. This chart illustrates how OmniAb Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for OmniAb Inc. for real-time trading data and today's change.
OmniAb Inc. Cash Flow Conversion Ratio Explained
OmniAb Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
OmniAb Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OmniAb Inc. ranked by their cash flow conversion efficiency. Also see how much is OmniAb Inc. worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Skandinaviska Enskilda Banken AB (publ)
ST:SEB-C
|
1.189x |
|
Haier Smart Home Co Ltd
XETRA:690D
|
0.049x |
|
Autohellas S.A.
AT:OTOEL
|
0.064x |
|
Qingdao Hiron Commercial Cold Chain Co Ltd
SHG:603187
|
0.075x |
|
Fundamenta Real Estate AG
SW:FREN
|
0.015x |
|
Kangping Technology (Suzhou) Co. Ltd.
SHE:300907
|
0.018x |
|
Energy Resources of Australia Ltd
AU:ERA
|
0.079x |
|
Bright Oceans Inter Telecom Corp
SHG:600289
|
-0.244x |
Annual Cash Flow Conversion Efficiency for OmniAb Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of OmniAb Inc. from 2019 to 2025. Review OABI cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $267.03 Million | $-36.45 Million | -0.137x | +1.00% |
| 2024-12-31 | $287.62 Million | $-39.66 Million | -0.138x | -1948.44% |
| 2023-12-31 | $314.58 Million | $2.35 Million | 0.007x | +171.00% |
| 2022-12-31 | $341.37 Million | $-3.59 Million | -0.011x | +56.59% |
| 2021-12-31 | $234.31 Million | $-5.67 Million | -0.024x | -257.55% |
| 2020-12-31 | $235.54 Million | $3.62 Million | 0.015x | +164.53% |
| 2019-12-31 | $218.19 Million | $-5.20 Million | -0.024x | -- |
About OmniAb Inc.
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partne… Read more